Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TARZAN: Radiotherapy Followed by Atezolizumab and Bevacizumab in Rectal Cancer
NCT04017455Phase 2Active, not recruiting
- Sponsor
- Netherlands Cancer Institute
- Start
- Oct 2019
- Primary completion
- Dec 2028
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of atezolizumab, bevacizumab in rectal cancer, sponsored by Netherlands Cancer Institute. Started Oct 2019; status: active, not recruiting.
02
Drugs
atezolizumabbevacizumab
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT04017455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04017455.